Most Clicked StoriesMore >


Sanofi wins FDA approval for Thymoglobulin

BIO SmartBrief | Apr 25, 2017

Sanofi's Thymoglobulin has been approved by the FDA as a treatment to be used in conjunction with concomitant immunosuppression for the prevention of acute kidney transplant rejection in patients. Reuters (04/24)


HitGen partners with Scripps, Calibr for drug discovery

BIO SmartBrief | Apr 24, 2017

Fresenius to acquire Akorn, biosimilar business of Merck KGaA

BIO SmartBrief | Apr 26, 2017

FDA approves sBLA from Regeneron, Sanofi for cholesterol injection

BIO SmartBrief | Apr 26, 2017

BioMarin's Batten disease drug wins FDA nod

BIO SmartBrief | Apr 28, 2017

Samsung wins FDA approval for Remicade biosimilar

BIO SmartBrief | Apr 24, 2017

Forge Therapeutics raises $15M

BIO SmartBrief | Apr 26, 2017

New drug application for CF is OK'd by FDA, Health Canada

BIO SmartBrief | Apr 25, 2017

EMA, FDA consider joint activities on accelerated evaluations

BIO SmartBrief | Apr 24, 2017

IPO could generate $74.8M for Argenx

BIO SmartBrief | Apr 24, 2017


Find BIO SmartBrief Issues by Date:



BIO News More >


BIO Action

BIO SmartBrief | Apr 28, 2017

Register for BIO Talent Connect, BIO's Career Growth Opportunity at BIO 2017

BIO SmartBrief | Apr 28, 2017

Register for BIO's Executive Training courses

BIO SmartBrief | Apr 27, 2017

Take advantage of your cost-savings opportunities

BIO SmartBrief | Apr 27, 2017

BusinessWire -- Latest version

BIO SmartBrief | Apr 26, 2017




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more